| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.07 | 0.4 |